QUARANTELLI, MARIO
 Distribuzione geografica
Continente #
AS - Asia 3.830
NA - Nord America 2.060
EU - Europa 883
SA - Sud America 712
Continente sconosciuto - Info sul continente non disponibili 104
AF - Africa 58
OC - Oceania 8
Totale 7.655
Nazione #
US - Stati Uniti d'America 1.936
SG - Singapore 1.634
CN - Cina 768
BR - Brasile 556
VN - Vietnam 392
HK - Hong Kong 389
IT - Italia 277
FR - Francia 244
JP - Giappone 142
BD - Bangladesh 135
KR - Corea 130
DE - Germania 66
IN - India 65
NL - Olanda 59
CA - Canada 57
AR - Argentina 53
FI - Finlandia 52
GB - Regno Unito 51
EC - Ecuador 34
ID - Indonesia 23
MX - Messico 23
TR - Turchia 22
ZA - Sudafrica 21
IQ - Iraq 20
IL - Israele 19
PL - Polonia 19
CO - Colombia 17
RU - Federazione Russa 16
AT - Austria 14
CL - Cile 13
PY - Paraguay 13
ES - Italia 12
SA - Arabia Saudita 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 10
MY - Malesia 10
SE - Svezia 10
UA - Ucraina 10
JM - Giamaica 9
KZ - Kazakistan 9
UY - Uruguay 8
IE - Irlanda 7
NI - Nicaragua 7
PK - Pakistan 7
TH - Thailandia 7
AL - Albania 6
MA - Marocco 6
UZ - Uzbekistan 6
AU - Australia 5
CZ - Repubblica Ceca 5
GR - Grecia 5
CR - Costa Rica 4
EG - Egitto 4
GT - Guatemala 4
HN - Honduras 4
LT - Lituania 4
PE - Perù 4
TN - Tunisia 4
AZ - Azerbaigian 3
BB - Barbados 3
DZ - Algeria 3
HR - Croazia 3
JO - Giordania 3
KE - Kenya 3
KG - Kirghizistan 3
LB - Libano 3
NG - Nigeria 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PA - Panama 3
PR - Porto Rico 3
SN - Senegal 3
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GP - Guadalupe 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BE - Belgio 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
Totale 7.539
Città #
Singapore 1.023
Santa Clara 643
Hong Kong 386
Hefei 296
San Jose 211
Lauterbourg 190
Ashburn 160
Beijing 153
Ho Chi Minh City 141
Seoul 128
Tokyo 115
Hanoi 108
Los Angeles 102
New York 58
São Paulo 47
Naples 39
Helsinki 35
Guangzhou 28
Dallas 27
Milan 27
Rome 27
Afragola 22
Frankfurt am Main 21
Orem 20
Council Bluffs 19
Minamishinagawa 19
Buffalo 18
Haiphong 18
Phoenix 16
Bengaluru 15
Brasília 15
Montreal 15
Rio de Janeiro 15
Toronto 14
Warsaw 14
Johannesburg 12
Lappeenranta 12
Nuremberg 12
Quito 12
Da Nang 11
Atlanta 10
Belo Horizonte 9
Santo André 9
Shanghai 9
Stockholm 9
Boston 8
Casandrino 8
Curitiba 8
Düsseldorf 8
Houston 8
London 8
Mumbai 8
Porto Alegre 8
Portsmouth 8
Salvador 8
Brooklyn 7
Can Tho 7
Dubai 7
Guayaquil 7
Kingston 7
Managua 7
Manchester 7
Montevideo 7
Newark 7
Quận Bình Thạnh 7
Santiago 7
Vienna 7
Ankara 6
Bauru 6
Buenos Aires 6
Denver 6
Dublin 6
Elk Grove Village 6
Falkenstein 6
Florence 6
Hải Dương 6
Istanbul 6
Jakarta 6
Kyiv 6
Paris 6
Philadelphia 6
San Francisco 6
Tashkent 6
Amsterdam 5
Baghdad 5
Biên Hòa 5
Casablanca 5
Chennai 5
Chicago 5
Contagem 5
Goiânia 5
Guarujá 5
Guarulhos 5
Ha Long 5
Jacksonville 5
Jeddah 5
João Pessoa 5
Miami 5
Tirana 5
Turku 5
Totale 4.635
Nome #
Abnormal or delayed development of the posterior membranous area of the brain: anatomy, ultrasound diagnosis, natural history and outcome of Blake's pouch cyst in the fetus 117
DTI and attention function. Dose-response evaluation in partial brain irradiation 116
A polynomial regression-based approach to estimate relaxation rate maps suitable for multiparametric segmentation of clinical brain MRI studies in multiple sclerosis 97
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma 94
Imaging of Brain TSPO Expression in a Mouse Model of Amyotrophic Lateral Sclerosis with [18F]DPA-714 and Micro-PET/CT. 90
Imaging of brain TSPO expression in a mouse model of stroke with [18F]DPA-714 and micro-PET 87
In vivo imaging of CNS microglial activation/macrophage infiltration with combined [F-18]DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis 83
White matter structural connectivity abnormalities in subjects with deficit schizophrenia: A diffusion tensor imaging study 81
Avolition-Apathy and White Matter Connectivity in Schizophrenia: Reduced Fractional Anisotropy Between Amygdala and Insular Cortex 81
In vivo imaging and characterization of [F-18]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET 80
Flexibility of brain dynamics is increased and predicts clinical impairment in relapsing–remitting but not in secondary progressive multiple sclerosis 79
ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial 74
Imaging of brain TSPO expression with [18F]DPA-714 PET/CT and immunofluorescence analysis in mouse model of ALS. 73
CYP7B1 screening in multiple sclerosis patients shows association among new variants, pyramidal signs and autoimmune disease 72
Voxel-based analysis of gray matter relaxation rates shows different correlation patterns for cognitive impairment and physical disability in relapsing-remitting multiple sclerosis 69
Estimating brain atrophy in clinical settings: linear measures of ventricular enlargement for evaluation of disease activity and long-term disability progression in Multiple Sclerosis 66
Biofeedback Rehabilitation in Patients with Stargardt disease: a randomized controlled trial 62
Clinical correlates of R1 relaxometry and magnetic susceptibility changes in multiple sclerosis: a multi-parameter quantitative MRI study of brain iron and myelin 62
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon Beta-1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study) 62
Grey: white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression 61
In vivo study of biodistribution and specific binding of [18 F] DPA-714, a traslocator protein-specific (TSPO) radioligand, in mice with microPET-CT. 60
Whole-Brain Propagation Delays in Multiple Sclerosis, a Combined Tractography-Magnetoencephalography Study 59
Stratification of multiple sclerosis patients using unsupervised machine learning: a single-visit MRI-driven approach 58
Jugular foramen stenosis in external hydrocephalus in infants 57
Multivariate Fuzzy Analysis of Brain Tissue Volumes and Relaxation Rates for Supporting the Diagnosis of Relapsing- Remitting Multiple Sclerosis 57
Efficacy, safety and tolerability of Atorvastatin in patients with Relapsing-remitting multiple sclerosis in treAtment with INterferoN-beta (ARIANNA): a multicentre, randomised, double-blind, placebo-controlled, parallel-group-study 57
Dynamical interactions reconfigure the gradient of cortical timescales 56
The structural connectome constrains fast brain dynamics 55
An MRI digital brain phantom for validation of segmentation methods 55
Correction to: Clinical correlates of R1 relaxometry and magnetic susceptibility changes in multiple sclerosis: a multi-parameter quantitative MRI study of brain iron and myelin (European Radiology, (2022), 33, 3, (2185-2194), 10.1007/s00330-022-09154-y) 55
StepBrain: A 3-Dimensionally Printed Multicompartmental Anthropomorphic Brain Phantom to Simulate PET Activity Distributions 55
Fully automated measurement of intracranial CSF and brain parenchyma volumes in pediatric hydrocephalus by segmentation of clinical MRI studies 55
Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy 54
In vivo imaging and characterization of [18F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET 54
Brain alteration in a Nude/SCID fetus carrying FOXN1 homozygous mutation 53
In vivo biodistribution and specific binding of 18F-DPA-714, a Traslocator Protein-Specific (TSPO) radioligand, in mice with microPET-CT. 53
2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosis 53
Brain atrophy in Relapsing-remitting multiple sclerosis patients treated with interferon-beta and atorvastatin (The ARIANNA study) 53
Biofeedback Rehabilitation and Visual Cortex Response in Stargardt's Disease: A Randomized Controlled Trial 53
Magnetic resonance parkinsonism indices and interpeduncular angle in idiopathic normal pressure hydrocephalus and progressive supranuclear palsy 51
Investigating the Relationship between White Matter Connectivity and Motivational Circuits in Subjects with Deficit Schizophrenia: A Diffusion Tensor Imaging (DTI) Study 49
A Voxel-Based Approach to Explore Local Dose Differences Associated With Radiation-Induced Lung Damage 48
Default-Mode Network Connectivity Changes Correlate with Attention Deficits in ALL Long-Term Survivors Treated with Radio-and/or Chemotherapy 48
Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load. 47
Reduced Striatal DAT Uptake Normalizes After Shunt in Normal-Pressure Hydrocephalus 46
Multimodal mri assessment of thalamic structural changes in earthquake survivors 46
Changes in venous drainage after posterior cranial vault distraction and foramen magnum decompression in syndromic craniosynostosis 46
Searching for the grail: may machine learning be a road to clinical use of brain MRI segmentation? 46
Clinical indications and acquisition protocol for the use of dynamic contrast-enhanced MRI in head and neck cancer squamous cell carcinoma: recommendations from an expert panel 46
A combined radiomics and machine learning approach to overcome the clinicoradiologic paradox in multiple sclerosis 45
A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results 45
Current status and future prospective of neuroimaging for epilepsy 45
Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment 45
Functional connectivity of the cortico-subcortical sensorimotor loop is modulated by the severity of nigrostriatal dopaminergic denervation in Parkinson's Disease 45
SPG5 and multiple sclerosis: Clinical and genetic overlap? 44
Feasibility of tract based dosimetric analysis in brain tumor patients 44
Regional Dose Differences Associated with Radiation-Induced Acute Severe Dysphagia 44
Unraveling deep gray matter atrophy and iron and myelin changes in multiple sclerosis 44
Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks. 43
Voxel Based Analysis of Dose Maps: Are We Addressing the Right Strategy? 43
Frequency encoding for simultaneous display of multimodality images 43
Relationship between Clinical Aspects in Early Phases of Relapsing-Remitting Multiple Sclerosis and Subsequent Brain Volume Changes 42
A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results. 42
Automated delineation of brain structures in patients undergoing radiotherapy for primary brain tumors: From atlas to dose-volume histograms. 41
Extra-osseous Tc-99m methylene diphosphonate uptake detected enlargement of the knee joint in patient with polyarthritis 41
Pro-inflammatory biomarkers predictive of poor response to Interferon beta1a in multiple sclerosis 40
Modifications of brain tissue volumes in facioscapulohumeral dystrophy 40
SPECT imaging of GABA(A)/benzodiazepine receptors and cerebral perfusion in mild cognitive impairment 39
Integrated software for the analysis of brain PET/SPECT studies with Partial Volume Effect Correction 38
Is advanced neuroimaging for neuroradiologists? A systematic review of the scientific literature of the last decade 38
Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity 38
Reproducibility of intracranial volume measurement by unsupervised multispectral brain segmentation 38
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS 37
Accuracy of neurosonography and MRI in clinical management of fetuses referred with central nervous system abnormalities 37
A voxel-based morphometry study of disease severity correlates in relapsing-remitting multiple sclerosis 36
Relationship between Clinical Aspects in Early Phases of Relapsing-Remitting Multiple Sclerosis and Subsequent Brain Volume Changes 36
Measurement of global brain atrophy in Alzheimer's disease with unsupervised segmentation of spin-echo MRI studies 36
Generalized formalism of the Extended Phase Diagram and computational applications including an MRI simulator 36
Assessment of scanner performance and normalization of estimated relaxation rate values 36
Avolition and microstructural brain abnormalities in Schizophrenia: Reduced fractional anisotropy in pathways connecting amygdala and insular cortex 36
Unsupervised, automated segmentation of the normal brain using a multispectral relaxometric magnetic resonance approach 35
Grey/white matter ratio at diagnosis, and the risk of 10-year multiple sclerosis progression 35
Automated segmentation and measurement of global white matter lesion volume in patients with multiple sclerosis 35
Visual Cortex Activation in Patients With Stargardt Disease 35
Efficacy, safety and tolerability of Atorvastatin in patients with Relapsing-remitting multiple sclerosis in treAtment with INterferoN-betA (ARIANNA): a multicentre, randomised, double-blind, placebo-controlled, parallel-group-study, Lyon. France 34
Relationship between simultaneously acquired resting-state regional cerebral glucose metabolism and functional MRI: A PET/MR hybrid scanner study 34
Avolition and structural connectivity in schizophrenia: evidence of reduced white matter integrity between amygdala and insular cortex 34
Is brain atrophy progression in RR-MS slowed by the association off atorvastatin and interferon beta-1a? Preliminary results from an open-label, randomized, clinical study 34
Functional MRI signal fluctuations highlight altered resting brain activity in Huntington's disease 33
Interferon beta-1a and atorvastatin combination therapy: 12-month results from an open-label, randomized, clinical study 33
Brain Morphometry Correlates of Pharmacoresistancy in Schizophrenia 33
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice 32
Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability. 31
Large infratentorial subdural hemorrhage diagnosed by ultrasound and MRI in a second-trimester fetus 31
A Blood Test for the Diagnosis of Multiple Sclerosis 31
Pragmatic abilities in multiple sclerosis: An rs-fMRI study 31
Brain atrophy and lesion load in a large population of patients with multiple sclerosis. 31
Correlation of disease severity and regional brain tissue loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study in a large population 30
Grey matter loss in relapsing-remitting multiple sclerosis: a voxel - based morphometry study 30
Characteristics, associations and outcome of partial agenesis of the corpus callosum in the fetus. 30
Totale 5.040
Categoria #
all - tutte 27.500
article - articoli 25.809
book - libri 301
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.610


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202441 0 0 0 0 0 0 0 0 2 0 34 5
2024/20252.732 21 11 287 141 599 69 27 64 98 110 681 624
2025/20264.617 216 449 409 590 831 192 668 210 326 297 216 213
2026/2027265 252 13 0 0 0 0 0 0 0 0 0 0
Totale 7.655